skip to main content
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Lung Cancer remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer

Shaw, Alice T ; Bauer, Todd M ; de Marinis, Filippo ; Felip, Enriqueta ; Goto, Yasushi ; Liu, Geoffrey ; Mazieres, Julien ; Kim, Dong-Wan ; Mok, Tony ; Polli, Anna ; Thurm, Holger ; Calella, Anna M ; Peltz, Gerson ; Solomon, Benjamin J

The New England journal of medicine, 2020-11, Vol.383 (21), p.2018-2029 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

2
Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial

Shaw, Alice T ; Solomon, Benjamin J ; Chiari, Rita ; Riely, Gregory J ; Besse, Benjamin ; Soo, Ross A ; Kao, Steven ; Lin, Chia-Chi ; Bauer, Todd M ; Clancy, Jill S ; Thurm, Holger ; Martini, Jean-Francois ; Peltz, Gerson ; Abbattista, Antonello ; Li, Sherry ; Ou, Sai-Hong Ignatius

The lancet oncology, 2019-12, Vol.20 (12), p.1691-1701 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

3
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

Solomon, Benjamin J ; Mok, Tony ; Kim, Dong-Wan ; Wu, Yi-Long ; Nakagawa, Kazuhiko ; Mekhail, Tarek ; Felip, Enriqueta ; Cappuzzo, Federico ; Paolini, Jolanda ; Usari, Tiziana ; Iyer, Shrividya ; Reisman, Arlene ; Wilner, Keith D ; Tursi, Jennifer ; Blackhall, Fiona

The New England journal of medicine, 2014-12, Vol.371 (23), p.2167-2177 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

4
Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial

Shaw, Alice T ; Felip, Enriqueta ; Bauer, Todd M ; Besse, Benjamin ; Navarro, Alejandro ; Postel-Vinay, Sophie ; Gainor, Justin F ; Johnson, Melissa ; Dietrich, Jorg ; James, Leonard P ; Clancy, Jill S ; Chen, Joseph ; Martini, Jean-François ; Abbattista, Antonello ; Solomon, Benjamin J

The lancet oncology, 2017-12, Vol.18 (12), p.1590-1599 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

5
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration
Material Type:
Artigo
Adicionar ao Meu Espaço

Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration

Drilon, Alexander ; Clark, Jeffrey W ; Weiss, Jared ; Ou, Sai-Hong Ignatius ; Camidge, D Ross ; Solomon, Benjamin J ; Otterson, Gregory A ; Villaruz, Liza C ; Riely, Gregory J ; Heist, Rebecca S ; Awad, Mark M ; Shapiro, Geoffrey I ; Satouchi, Miyako ; Hida, Toyoaki ; Hayashi, Hidetoshi ; Murphy, Danielle A ; Wang, Sherry C ; Li, Sherry ; Usari, Tiziana ; Wilner, Keith D ; Paik, Paul K

Nature medicine, 2020-01, Vol.26 (1), p.47-51 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

6
Activity and safety of ceritinib in patients with ALK -rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Activity and safety of ceritinib in patients with ALK -rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial

Kim, Dong-Wan, MD ; Mehra, Ranee, MD ; Tan, Daniel S W, MD ; Felip, Enriqueta, MD ; Chow, Laura Q M, MD ; Camidge, D Ross, Prof ; Vansteenkiste, Johan, Prof ; Sharma, Sunil, Prof ; De Pas, Tommaso, MD ; Riely, Gregory J, MD ; Solomon, Benjamin J, MBBS ; Wolf, Jürgen, Prof ; Thomas, Michael, Prof ; Schuler, Martin, Prof ; Liu, Geoffrey, MD ; Santoro, Armando, Prof ; Sutradhar, Santosh, PhD ; Li, Siyu, PhD ; Szczudlo, Tomasz, MD ; Yovine, Alejandro, MD ; Shaw, Alice T, Dr

The lancet oncology, 2016-04, Vol.17 (4), p.452-463 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

7
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study
Material Type:
Artigo
Adicionar ao Meu Espaço

Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study

Solomon, Benjamin J ; Besse, Benjamin ; Bauer, Todd M ; Felip, Enriqueta ; Soo, Ross A ; Camidge, D Ross ; Chiari, Rita ; Bearz, Alessandra ; Lin, Chia-Chi ; Gadgeel, Shirish M ; Riely, Gregory J ; Tan, Eng Huat ; Seto, Takashi ; James, Leonard P ; Clancy, Jill S ; Abbattista, Antonello ; Martini, Jean-François ; Chen, Joseph ; Peltz, Gerson ; Thurm, Holger ; Ou, Sai-Hong Ignatius ; Shaw, Alice T

The lancet oncology, 2018-12, Vol.19 (12), p.1654-1667 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

8
Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer

Shaw, Alice T ; Ou, Sai-Hong I ; Bang, Yung-Jue ; Camidge, D. Ross ; Solomon, Benjamin J ; Salgia, Ravi ; Riely, Gregory J ; Varella-Garcia, Marileila ; Shapiro, Geoffrey I ; Costa, Daniel B ; Doebele, Robert C ; Le, Long Phi ; Zheng, Zongli ; Tan, Weiwei ; Stephenson, Patricia ; Shreeve, S. Martin ; Tye, Lesley M ; Christensen, James G ; Wilner, Keith D ; Clark, Jeffrey W ; Iafrate, A. John

The New England journal of medicine, 2014-11, Vol.371 (21), p.1963-1971 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

9
Clinical Management of Adverse Events Associated with Lorlatinib
Material Type:
Artigo
Adicionar ao Meu Espaço

Clinical Management of Adverse Events Associated with Lorlatinib

Bauer, Todd M. ; Felip, Enriqueta ; Solomon, Benjamin J. ; Thurm, Holger ; Peltz, Gerson ; Chioda, Marc D. ; Shaw, Alice T.

The oncologist (Dayton, Ohio), 2019-08, Vol.24 (8), p.1103-1110 [Periódico revisado por pares]

Hoboken, USA: John Wiley & Sons, Inc

Texto completo disponível

10
Targeting ROS1 Rearrangements in Non-small Cell Lung Cancer: Crizotinib and Newer Generation Tyrosine Kinase Inhibitors
Material Type:
Artigo
Adicionar ao Meu Espaço

Targeting ROS1 Rearrangements in Non-small Cell Lung Cancer: Crizotinib and Newer Generation Tyrosine Kinase Inhibitors

Morris, Tessa A. ; Khoo, Christine ; Solomon, Benjamin J.

Drugs (New York, N.Y.), 2019-08, Vol.79 (12), p.1277-1286 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (66)
  2. Revistas revisadas por pares (67)

Data de Publicação 

De até
  1. Antes de2011  (3)
  2. 2011Até2013  (6)
  3. 2014Até2016  (16)
  4. 2017Até2020  (25)
  5. Após 2020  (23)
  6. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.